Algo version: 0.98b
Genovis AB (publ.) is listed at the STO Exchange
Genovis AB (publ.) [GENO.ST]
STO Sector: Healthcare Industry:Biotechnology

Is Genovis AB (publ.) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Genovis AB (publ.) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK19.60, you would have made a profit of SEK3.85 per share or 19.64%

Yes, the average daily trading liquidity for Genovis AB (publ.) is SEK87 678 thousand. You should therefore be able to get in and out of your positions relatively fast.

Genovis AB (publ.) has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 11.40, the company's ability to pay off the debt is good. Genovis AB (publ.) has a very good net profit margin of 23.78% and should have very high tolerances against inflation.

We have calculated the inflation risk for Genovis AB (publ.) to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.